2015
DOI: 10.1097/tp.0000000000000746
|View full text |Cite
|
Sign up to set email alerts
|

Transgenic Expression of Human CD46 on Porcine Endothelium

Abstract: In this human-to-pig xenoperfusion model, complement inhibition by transgenic hCD46 expression led to a significant inhibition of procoagulant and antifibrinolytic pathways.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 66 publications
0
2
0
Order By: Relevance
“…To analyse whether animals infected with PCMV/PRV could present alteration in the coagulation system, tissue plasminogen activator (tPA) and plasminogen activator inhibitor 1 complexes (tPA-PAI-1) were measured in plasma samples by an ELISA 31 . Interestingly, we observed that baboons P and Q, which presented clear pathological alterations, also had very high levels of tPA-PAI-1 complexes (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…To analyse whether animals infected with PCMV/PRV could present alteration in the coagulation system, tissue plasminogen activator (tPA) and plasminogen activator inhibitor 1 complexes (tPA-PAI-1) were measured in plasma samples by an ELISA 31 . Interestingly, we observed that baboons P and Q, which presented clear pathological alterations, also had very high levels of tPA-PAI-1 complexes (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The full requirements for clinically effective xenotransplantation will become evident as transplant studies continue and salient aspects of delayed xenograft rejection are revealed. Although CD46 affects coagulation and fibrinolytic cascades 54 further transgenes may be required to combat coagulation dysregulation and thrombotic microangiopathy associated with endothelial activation. Candidate transgenes for future inclusion thus include human anticoagulant thrombomodulin 55 , the endothelium protein C receptor 56 and CD39 57 .…”
Section: Discussionmentioning
confidence: 99%